nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—Valproic Acid—CYP1A2—type 2 diabetes mellitus	0.0159	0.476	CrCbGaD
Anisotropine Methylbromide—Valproic Acid—CYP3A4—type 2 diabetes mellitus	0.0105	0.315	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CYP3A4—type 2 diabetes mellitus	0.00702	0.21	CrCbGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000303	0.000314	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000302	0.000313	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000302	0.000312	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000301	0.000311	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000301	0.000311	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.0003	0.000311	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.0003	0.00031	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	0.0003	0.00031	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	0.0003	0.00031	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000299	0.00031	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000299	0.000309	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000298	0.000308	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000298	0.000308	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000297	0.000307	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000297	0.000307	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000295	0.000305	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000295	0.000305	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000294	0.000304	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000292	0.000302	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000291	0.000301	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000288	0.000298	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000287	0.000297	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	0.000287	0.000297	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000287	0.000297	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000286	0.000296	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000285	0.000295	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000285	0.000294	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000283	0.000292	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000279	0.000288	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000278	0.000288	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000278	0.000288	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000278	0.000287	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000277	0.000287	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000277	0.000287	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000275	0.000285	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000274	0.000284	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000274	0.000284	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000274	0.000283	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000273	0.000282	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.00027	0.00028	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.00027	0.00028	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.00027	0.000279	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000269	0.000279	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000269	0.000279	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000268	0.000278	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000268	0.000278	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000267	0.000276	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000266	0.000275	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000266	0.000275	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000265	0.000274	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000264	0.000273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000264	0.000273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000264	0.000273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000263	0.000272	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000263	0.000272	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000261	0.00027	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.00026	0.000269	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.00026	0.000269	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.00026	0.000269	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000259	0.000268	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000257	0.000266	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000253	0.000262	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000252	0.000261	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.00025	0.000258	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	0.000248	0.000256	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000248	0.000256	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	0.000247	0.000255	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000245	0.000254	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000244	0.000253	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000244	0.000252	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000243	0.000252	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	0.000243	0.000252	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000242	0.00025	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000241	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000241	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000241	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	0.00024	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.00024	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000238	0.000246	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000238	0.000246	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000237	0.000245	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000236	0.000245	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000236	0.000245	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	0.000236	0.000244	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000236	0.000244	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000234	0.000242	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000233	0.000241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	0.00023	0.000238	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000226	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	0.000225	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000225	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000223	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000222	0.000229	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000221	0.000229	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000221	0.000229	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	0.000221	0.000228	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000221	0.000228	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	0.00022	0.000228	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000219	0.000226	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000219	0.000226	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	0.000214	0.000222	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000212	0.000219	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.00021	0.000217	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000209	0.000216	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000208	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000207	0.000214	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000207	0.000214	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000205	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000205	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000205	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000204	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000204	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000204	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000203	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000203	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	0.000203	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000202	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000202	0.000209	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000202	0.000209	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000201	0.000208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000201	0.000208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000201	0.000207	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.0002	0.000207	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	0.000199	0.000206	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000198	0.000205	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000198	0.000205	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000197	0.000204	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000197	0.000204	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000197	0.000203	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000196	0.000202	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000195	0.000202	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000195	0.000201	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000194	0.000201	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	0.000193	0.0002	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000192	0.000199	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	0.00019	0.000196	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000189	0.000196	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	0.000189	0.000196	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000189	0.000195	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	0.000187	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000187	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000185	0.000192	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000185	0.000191	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000183	0.000189	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000177	0.000184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000177	0.000183	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000175	0.000181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000174	0.00018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000174	0.00018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000172	0.000178	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	0.00017	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	0.00017	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	0.000168	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	0.000165	0.00017	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000162	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000162	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000162	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000162	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000161	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—INS—type 2 diabetes mellitus	0.000161	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000161	0.000167	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.00016	0.000166	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.00016	0.000165	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	0.00016	0.000165	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000159	0.000165	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000159	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000159	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000159	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000158	0.000163	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000158	0.000163	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000157	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000157	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000156	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000156	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000156	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000155	0.00016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000149	0.000155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000149	0.000154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	0.000148	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000148	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	0.000142	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000142	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000141	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000141	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.00014	0.000144	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	0.000135	0.00014	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	0.000135	0.00014	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	0.000134	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000133	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000133	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000132	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000131	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000131	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000131	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.00013	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.00013	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.00013	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	0.000129	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000129	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000129	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000129	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000124	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000124	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000123	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000119	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000119	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000118	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000118	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000117	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000117	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000112	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000111	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	0.00011	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000102	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000101	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.000101	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.000101	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.0001	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	0.0001	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.99e-05	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.95e-05	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.89e-05	0.000102	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.53e-05	9.86e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.5e-05	9.83e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.43e-05	9.75e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.41e-05	9.73e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.4e-05	9.72e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.31e-05	9.63e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.24e-05	9.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.21e-05	9.53e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.12e-05	9.44e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.78e-05	9.09e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	8.76e-05	9.06e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.67e-05	8.97e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.56e-05	8.85e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.53e-05	8.82e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.45e-05	8.74e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.85e-05	8.13e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.83e-05	8.1e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.75e-05	8.02e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.7e-05	7.97e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.68e-05	7.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.6e-05	7.86e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	6.51e-05	6.73e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.92e-05	6.12e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.9e-05	6.1e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.84e-05	6.04e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.46e-05	5.65e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.44e-05	5.63e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.39e-05	5.58e-05	CbGpPWpGaD
